Daniel Lock, Specialist - Pharmaceutical Development shares his insights on the evolution of nebulisers, and how advancements in technology can improve patient care and inhaled product development. In this episode, Dan discusses how smart nebulisers can improve lung deposition for inhaled therapies, provide valuable patient data in clinical trials, and expand the profile of patients who may benefit from nebulised treatment.